People with damage in the small blood vessels of the retina and kidneys are at increased risk to develop the most common type of abnormal heart rhythm, according to research presented at the American Heart Association's Scientific Sessions 2013.
Atrial fibrillation raises the risk of stroke and causes heart-related chest pain or heart failure in some people.
Researchers in the Atherosclerosis Risk in Communities Study (ARIC) followed 10,009 middle-aged people for an average 13.6 years. Atrial fibrillation developed at a rate of:
- 5.7 incidences per 1,000 person-years in those with no retina or kidney changes.
- 8.9 incidences per 1,000 person-years in those with signs of small vessel damage in the retina, such as micro-bleeds or micro-aneurysms.
- 16.8 incidences per 1,000 person-years in those with signs of vessel damage in the kidneys, allowing tiny amounts of protein to be released into their urine (micro-albuminuria).
- 24.4 incidences per 1,000 person-years in those with both retinopathy and micro-albuminuria.
Though reasons for the association are unclear, changes in other vascular beds may serve as a representation of coronary micro-vascular changes and the observed association may be mediated via inflammation, endothelial dysfunction, autonomic dysfunction, and electro-mechanical remodeling, the researchers said.
The ARIC study is funded by the National Heart, Lung, and Blood Institute; National Institutes of Health. Author disclosures are listed in the abstract.
For more news from AHA Scientific Sessions 2013 follow us on Twitter @HeartNews #AHA13.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.
Additional resources related to these tips are on the right column of the release link at http://newsroom.heart.org/news/monday-news-tips-2563028?preview=33a9c0eba00d53ad8e2e23fa06f34915.